FDA Import Refusal AEK-9054896-5/10003/1 — Abbvie Corporation
The FDA refused shipment AEK-9054896-5/10003/1 from Abbvie Corporation (Canada) on Jan 21, 2026. The refused product falls under Drugs and Biologics — ANTIMIGRAINE, NEC. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 21, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58CCA99 ANTIMIGRAINE, NEC
- Charges
- 118,75